Related Experiment Videos
[Diabetes and heart transplantation]
M Loebe1, K Ramasubbu, D J Hamilton
1Direktor Lungentransplantation, Department of Surgery, Baylor College of Medicine, 6560 Fannin Suite 1860, Houston TX 77030, USA. mloebe@bcm.tmc.edu
Summary
Diabetes in heart transplant recipients has comparable long-term outcomes to non-diabetic patients. Post-transplant diabetes, often temporary, requires careful management of immunosuppressive therapy for optimal glucose control.
Area of Science:
- Cardiology
- Endocrinology
- Transplantation Medicine
Context:
- Diabetes is common in end-stage heart failure patients awaiting transplantation.
- Historically, diabetes was a contraindication for heart transplantation.
- Current practices allow for successful transplantation in diabetic patients.
Purpose:
- To evaluate the outcomes of heart transplantation in diabetic patients.
- To identify risk factors and characteristics of post-transplant diabetes.
- To inform management strategies for glucose intolerance in heart transplant recipients.
Summary:
- Diabetic patients achieve long-term outcomes comparable to non-diabetic recipients after heart transplantation with careful management.
- Approximately one-third of heart transplant recipients develop post-transplant diabetes, often transient.
- Diabetes does not significantly impact rejection rates, malignancies, or transplant vasculopathy.
Impact:
- Individualized preoperative assessment and postoperative medication are crucial for successful outcomes.
- Awareness of medication impact on glucose metabolism is vital for immunosuppressive therapy planning.
- Multidisciplinary team management ensures effective monitoring and treatment of diabetes post-transplant.